Pharmaceutical - India

Filter

Current filters:

India

Popular Filters

1 to 25 of 61 results

Indian Health Ministry seeking compulsory license for B-MS’ Sprycel

Indian Health Ministry seeking compulsory license for B-MS’ Sprycel

19-08-2014

Anti-leukemia drug dasatinib, made by US pharma major Bristol-Myers Squibb and sold in India under the…

Bristol-Myers SquibbDasatinibIndiaOncologyPatentsPharmaceuticalSprycel

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

11-08-2014

The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Sanofi partners with Emcure for oncology portfolio in India

Sanofi partners with Emcure for oncology portfolio in India

06-08-2014

French pharma major Sanofi’s Indian subsidiary said today that it has entered into a marketing and…

Emcure PharmaceuticalsFasturtecFludaraIndiaJevtanaMarkets & MarketingOncologyPharmaceuticalSanofiTaxotere

Elder to strengthen existing brands following sale to Torrent

Elder to strengthen existing brands following sale to Torrent

18-07-2014

Indian drugmaker Elder Pharma has said it plans to strengthen its existing brands including Eldervit…

Elder PharmaceuticalsFinancialIndiaPharmaceuticalTorrent GroupTorrent Pharmaceuticals

Packaging and delivery specialist West opens first plant in India

Packaging and delivery specialist West opens first plant in India

16-07-2014

US packaging and delivery company West has dedicated its manufacturing plant in the Sri City Special…

ChennaiIndiaPharmaceuticalProductionSri CityWest

Multinational and Indian drugmakers to face another price cap

Multinational and Indian drugmakers to face another price cap

15-07-2014

In a major blow to drug companies, India's National Pharmaceutical Pricing Authority (NPPA) has decided…

IndiaNational Pharmaceutical Pricing AuthorityPharmaceuticalPricing

Further Indian drug price cuts, and price control categorization likely

30-06-2014

In order to make drugs more affordable to the country’s public, the Indian government is likely to…

FinancialIndiaPharmaceuticalPoliticsPricing

New drug prices in India to be capped by NPPA

New drug prices in India to be capped by NPPA

16-06-2014

In order to keep a lid on the escalating cost of drugs, India's drug price regulator has decided to fix…

IndiaMachineryNatco PharmaPharmaceuticalPharmacyPoliticsPricingRetail priceSun Pharmaceuticals

Indian draft guidelines for clinical trial compensation for medical management

Indian draft guidelines for clinical trial compensation for medical management

10-06-2014

India's Ministry of Health has released new and revised draft guidelines on compensation to be paid for…

FinancialIndiaPharmaceuticalResearch

Glenmark opens new MAb manufacturing site in Switzerland

Glenmark opens new MAb manufacturing site in Switzerland

04-06-2014

Glenmark Pharmaceuticals SA (GPSA), a wholly-owned subsidiary of India’s Glenmark Pharmaceuticals,…

AnalgesiaEuropeGlenmark PharmaceuticalsIndiaMonoclonal antibodiesPharmaceuticalProduction

BRIC nations identified as emerging leaders in global clinical trials landscape

BRIC nations identified as emerging leaders in global clinical trials landscape

28-05-2014

Despite challenges, increasing health care budgets and advancing markets in BRIC (Brazil, Russia, India…

BrazilChinaIndiaPharmaceuticalResearchRussia

UK’s MHRA seizes £8.6 million of counterfeit, controlled and unlicensed medicines

26-05-2014

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) revealed last week that it has seized…

ChinaIndiaMarkets & MarketingPharmaceuticalRegulationUK

Ranbaxy reports loss for March fiscal quarter

Ranbaxy reports loss for March fiscal quarter

12-05-2014

Indian drug maker Ranbaxy Laboratories, majority-owned by Japan’s Daiichi Sankyo and subject of an…

FinancialIndiaPharmaceuticalRanbaxy Laboratories

Indian govt to penalize drugmakers for overcharging

Indian govt to penalize drugmakers for overcharging

06-05-2014

In a major crackdown, India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA)…

CiplaFinancialGlaxoSmithKlineIndiaPharmaceuticalPricing

USTR expresses growing concerns on IP protection in India and other markets

01-05-2014

The Office of the US Trade Representative (USTR) has released its annual “Special 301” Report on…

CanadaIndiaPatentsPharmaceuticalUSA

Pharma MNCs developing new pricing and market access strategies for India

01-05-2014

New research suggest that certain multinational pharmaceutical companies (MNCs) are experimenting with…

IndiaMarkets & MarketingPatentsPharmaceuticalPricing

India unrelenting over alleged lax IPR; may drag the USA to the WTO

28-04-2014

A clarion call has been sounded by Indian government officials, who are unwilling to buckle under pressure…

Asia-PacificIndiaPatentsPharmaceuticalPoliticsUSA

Indian regulator seeks to address the nation’s substandard drugs problem

Indian regulator seeks to address the nation’s substandard drugs problem

22-04-2014

In what is something of an indictment of India’s pharmaceutical industry, the Drug Controller General…

Asia-PacificIndiaPharmaceuticalProductionRegulation

India’s IPAB upholds Pfizer’s Detrol patent

India’s IPAB upholds Pfizer’s Detrol patent

27-03-2014

In a positive development for US drug giant Pfizer, India's Intellectual Property Appellate Board (IPAB)…

Asia-PacificDetrolGenito-urinaryIndiaPatentsPfizerPharmaceuticalRanbaxy Laboratories

1 to 25 of 61 results

Back to top